Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.

ABSTRACT:

SUBMITTER: McKenzie DR 

PROVIDER: S-EPMC8506107 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature